Notice for SARS-CoV-2 rS (NVX-CoV2373) (Biocelect Pty Ltd)
Active ingredients
SARS-CoV-2 rS (NVX-CoV2373)
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
Active immunisation of adults ≥ 18 years of age for the prevention of disease caused by SARS-CoV-2
Therapeutic area
Infectious diseases